person

Marlene F.

Country
Portugal
Department
Medical Management

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
1
Sites with multiple studies

Has run more than one trial at 1 of 1 partner site.

Specializations

Bioequivalence Studies

The investigator specializes in conducting comparative bioavailability studies with a particular focus on orodispersible tablet formulations. Their research examines the therapeutic equivalence of different drug delivery systems, specifically investigating Oxazepam at various dosage strengths.

  • Orodispersible tablet technologies
  • Comparative pharmaceutical formulations
  • Drug bioavailability assessment

Key interests include evaluating the performance of novel drug delivery systems against established reference products.

Addiction Medicine

The investigator conducts research in the field of nicotine addiction treatment, exploring innovative therapeutic approaches. Their work includes the evaluation of cytisinicline as a potential treatment option for smoking cessation.

  • Smoking cessation therapies
  • Addiction treatment assessment
  • Therapeutic safety evaluation

The research encompasses cardiac safety assessments through QT/QTc studies of therapeutic compounds.

Clinical Pharmacology

The investigator's expertise extends to clinical pharmacology with emphasis on drug safety and efficacy evaluation. Their work includes comprehensive assessment of pharmaceutical compounds through thorough QT studies and other clinical endpoints.

  • Drug safety assessment
  • Pharmacological evaluation
  • Clinical efficacy studies

Research focuses on establishing safety profiles of both therapeutic and supratherapeutic doses of investigational medications.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.